These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28205673)

  • 1. Increased Endovascular Staphylococcus aureus Inoculum Is the Link Between Elevated Serum Interleukin 10 Concentrations and Mortality in Patients With Bacteremia.
    Rose WE; Shukla SK; Berti AD; Hayney MS; Henriquez KM; Ranzoni A; Cooper MA; Proctor RA; Nizet V; Sakoulas G
    Clin Infect Dis; 2017 May; 64(10):1406-1412. PubMed ID: 28205673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia.
    Rose WE; Eickhoff JC; Shukla SK; Pantrangi M; Rooijakkers S; Cosgrove SE; Nizet V; Sakoulas G
    J Infect Dis; 2012 Nov; 206(10):1604-11. PubMed ID: 22966128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 2 downregulation and cytokine dysregulation predict mortality in patients with Staphylococcus aureus bacteremia.
    Kim NH; Sung JY; Choi YJ; Choi SJ; Ahn S; Ji E; Kim M; Kim CJ; Song KH; Choe PG; Park WB; Kim ES; Park KU; Kim NJ; Oh MD; Kim HB
    BMC Infect Dis; 2020 Nov; 20(1):901. PubMed ID: 33256638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
    Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
    Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Dysregulated Balance of Proinflammatory and Anti-Inflammatory Host Cytokine Response Early During Therapy Predicts Persistence and Mortality in Staphylococcus aureus Bacteremia.
    Minejima E; Bensman J; She RC; Mack WJ; Tuan Tran M; Ny P; Lou M; Yamaki J; Nieberg P; Ho J; Wong-Beringer A
    Crit Care Med; 2016 Apr; 44(4):671-9. PubMed ID: 26540400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and microbiological characteristics of persistent Staphylococcus aureus bacteremia, risk factors for mortality, and the role of CD4
    Yang E; Cho YG; Kim E; Chang E; Bae S; Jung J; Kim MJ; Chong YP; Kim SH; Choi SH; Lee SO; Chung YS; Kim YS
    Sci Rep; 2024 Jul; 14(1):15472. PubMed ID: 38969796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin (IL)-1β and IL-10 Host Responses in Patients With Staphylococcus aureus Bacteremia Determined by Antimicrobial Therapy.
    Volk CF; Burgdorf S; Edwardson G; Nizet V; Sakoulas G; Rose WE
    Clin Infect Dis; 2020 Jun; 70(12):2634-2640. PubMed ID: 31365924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation of virulence gene profiles of Staphylococcus aureus bacteremia isolates with mortality.
    Park KH; Greenwood-Quaintance KE; Cunningham SA; Rajagopalan G; Chia N; Jeraldo PR; Mandrekar J; Patel R
    Microb Pathog; 2019 Aug; 133():103543. PubMed ID: 31102653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of infective endocarditis and complicated infection in Staphylococcus aureus bacteremia - a retrospective cohort study on the role of bacteriuria.
    Bergenman O; Nilson B; Rasmussen M
    Eur J Clin Microbiol Infect Dis; 2024 Jul; 43(7):1419-1426. PubMed ID: 38771404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine measurements add value to clinical variables in predicting outcomes for Staphylococcus aureus bacteremia.
    Tan K; Minejima E; Lou M; Mack WJ; Nieberg P; Wong-Beringer A
    BMC Infect Dis; 2021 Apr; 21(1):317. PubMed ID: 33820537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low mortality of Staphylococcus aureus bacteremia in Icelandic children: nationwide study on incidence and outcome.
    Asgeirsson H; Gudlaugsson O; Kristinsson KG; Vilbergsson GR; Heiddal S; Haraldsson A; Weiland O; Kristjansson M
    Pediatr Infect Dis J; 2015 Feb; 34(2):140-4. PubMed ID: 24992124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
    Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
    Trials; 2019 May; 20(1):250. PubMed ID: 31046810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prognostic Model of Persistent Bacteremia and Mortality in Complicated Staphylococcus aureus Bloodstream Infection.
    Guimaraes AO; Cao Y; Hong K; Mayba O; Peck MC; Gutierrez J; Ruffin F; Carrasco-Triguero M; Dinoso JB; Clemenzi-Allen A; Koss CA; Maskarinec SA; Chambers HF; Fowler VG; Baruch A; Rosenberger CM
    Clin Infect Dis; 2019 Apr; 68(9):1502-1511. PubMed ID: 30165412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus.
    Falcón R; Mateo E; Oltra R; Giménez E; Albert E; Torres I; Navarro D
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):903-912. PubMed ID: 30729396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcus aureus bloodstream infection in patients with ventricular assist devices-Management and outcome in a prospective bicenter cohort.
    Joost I; Bothe W; Pausch C; Kaasch A; Lange B; Peyerl-Hoffmann G; Flüh G; Müller M; Schneider C; Seifert H; Kern WV; Beyersdorf F; Rieg S
    J Infect; 2018 Jul; 77(1):30-37. PubMed ID: 29778631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of delayed appropriate antimicrobial therapy on children with Staphylococcus aureus blood infection.
    Guo Z; Xu X; Zhang G; Wang X; Tian X; Li Y; Li Q; Chen D; Luo Z
    Eur J Pediatr; 2024 Sep; 183(9):3785-3796. PubMed ID: 38874791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing With Direct Physician Response for Management of Staphylococcus aureus Bacteremia.
    Eby JC; Richey MM; Platts-Mills JA; Mathers AJ; Novicoff WM; Cox HL
    Clin Infect Dis; 2018 Jan; 66(1):64-71. PubMed ID: 29020181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
    Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
    Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to blood culture positivity in Staphylococcus aureus bacteremia: association with 30-day mortality.
    Kim J; Gregson DB; Ross T; Laupland KB
    J Infect; 2010 Sep; 61(3):197-204. PubMed ID: 20547181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term mortality and causes of death associated with Staphylococcus aureus bacteremia. A matched cohort study.
    Gotland N; Uhre ML; Mejer N; Skov R; Petersen A; Larsen AR; Benfield T;
    J Infect; 2016 Oct; 73(4):346-57. PubMed ID: 27418382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.